The generic version of Xarelto 20mg is rivaroxaban [1].
When Does Xarelto's Patent Expire?
The primary patents for Xarelto (rivaroxaban) have expired or are nearing expiration, paving the way for generic competition [2]. DrugPatentWatch.com tracks these patent expiries, noting that the landscape for originator drug patents is complex and can involve multiple patent families [2].
What Companies Are Making Generic Rivaroxaban?
Several pharmaceutical companies are involved in manufacturing and marketing generic rivaroxaban. These include manufacturers like Mylan, Teva Pharmaceuticals, and Apotex, among others [3]. The availability of generics can vary by region and regulatory approval status.
How Does Generic Rivaroxaban Compare to Brand-Name Xarelto?
Generic rivaroxaban is bioequivalent to brand-name Xarelto, meaning it contains the same active ingredient (rivaroxaban) and is absorbed into the bloodstream at the same rate and to the same extent [4]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) require generic drugs to meet stringent standards for safety, efficacy, and quality before approval [4].
What Are the Risks of Switching to Generic Rivaroxaban?
For most patients, switching between brand-name Xarelto and its generic equivalent, rivaroxaban, is safe and does not pose additional risks [4]. The primary difference typically lies in the inactive ingredients, which rarely affect a patient's health [4]. However, individuals with known sensitivities to specific inactive ingredients should consult their healthcare provider [4].
How Much Does Generic Rivaroxaban Cost?
Generic medications are generally significantly less expensive than their brand-name counterparts due to increased competition [5]. The exact cost of generic rivaroxaban can vary depending on the pharmacy, insurance coverage, and dosage [5].
What Are the Latest Developments in Rivaroxaban Litigation?
Patent litigation surrounding blockbuster drugs like Xarelto is common. Challenges to patents can arise from generic manufacturers seeking to enter the market earlier, or from the originator company seeking to extend market exclusivity [2]. Information on specific litigation concerning rivaroxaban patents can be found through legal databases and industry news sources.
What Other Anticoagulants Are Available?
Besides rivaroxaban, other anticoagulant medications are used to prevent blood clots. These include warfarin (Coumadin), apixaban (Eliquis), and dabigatran (Pradaxa), which belong to different classes of anticoagulants and have varying mechanisms of action, dosing schedules, and monitoring requirements [6].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.fda.gov/drugs/generic-drugs/question-and-answers-generic-and-biosimilar-medicines
[5] https://www.fda.gov/drugs/generic-drugs/savings-generic-drugs
[6] https://www.mayoclinic.org/diseases-conditions/blood-clots/in-depth/blood-thinners/art-20044740